September 2026 KB Medical Group (KBMED) has secured a major government tender in Chile for sterile single-use syringes and hypodermic needles, marking another important step in the company’s continued expansion across Latin America. As the project moves through sample evaluation and implementation, KBMED is supporting the program with not only qualified medical devices, but also the regulatory documentation, batch traceability and international logistics required for complex

KBMED proudly announces that our single-use sterile syringes and safety needles have completed rollout across Spain’s national pharmacy...

KB Medical Group proudly announces that its blood collection tubes have successfully transitioned from the EU In Vitro Diagnostic...

W e are excited to announce that KB Medical Group will be showcasing our innovative solutions at MEDICA 2024 , the world’s leading...

We are pleased to share the latest business developments at KB Medical Group Inc. as we expand our presence into the veterinary...

I n the recent newsletter, we highlighted our business update in Germany , and our blood bag product line successfully passed a rigorous...

This is one of KBMED's long-time partners, who has been procuring KBMED's medical disposable syringes and infusion sets for years. Both...

KB Medical Group Inc. is one of the key players in the needlestick safety injection devices market with 510K cleared safety needles...

With over thirty years of proficiency in syringe and needle manufacturing, KBMED has consistently captured a substantial market share for...